Circ-EZH2 knockdown reverses DDAH1 and CBX3-mediated cell growth and invasion in glioma through miR-1265 sponge activity

被引:16
作者
Gao, Fengquan [1 ]
Du, Yan [1 ]
Zhang, Yun [1 ]
Ren, Deshuai [1 ]
Xu, Jiazhi [1 ]
Chen, Dagang [1 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 3, Dept Neurosurg, Qiqihar 161000, Peoples R China
关键词
Glioma; Circular RNA; circ-EZH2; miR-1265; DDAH1; CBX3; CANCER;
D O I
10.1016/j.gene.2019.144196
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Accumulating evidence has indicated the important roles of circular RNAs (circRNAs) in different tumors. However, their detailed regulatory mechanisms in glioma are not fully understood. In this study, the functional role of a novel circRNA, circ-EZH2, was investigated by cell counting kit-8 (CCK-8), colony formation, flow cytometry, and transwell experiments. The regulatory mechanism of circ-EZH2 was explored by bioinformatics analysis, quantitative real-time PCR (qRT-PCR), Western blot and dual-luciferase reporter assay. We identified that circ-EZH2 was overexpressed in glioma tissues and cell lines. Further studies revealed that ectopic expression of circ-EZH2 significantly promoted cell growth, migration and invasion but inhibited cell apoptosis. By contrast, silencing of circ-EZH2 induced the opposite effects. Additionally, we found circ-EZH2 served as a miRNA sponge for miR-1265 to release its suppression on DDAH1 and CBX3. Rescue assays further revealed that the oncogenic function of circ-EZH2 was partly dependent on its modulation of DDAH1 and CBX3. Our study unraveled a novel molecular pathway in glioma and may provide a new perspective for the treatment of glioma.
引用
收藏
页数:6
相关论文
共 28 条
[1]   Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ [J].
Akaike, Y. ;
Kuwano, Y. ;
Nishida, K. ;
Kurokawa, K. ;
Kajita, K. ;
Kano, S. ;
Masuda, K. ;
Rokutan, K. .
ONCOGENE, 2015, 34 (26) :3463-3473
[2]   CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer [J].
Chang, Shih-Chieh ;
Lai, Yi-Chun ;
Chen, Yen-Chung ;
Wang, Nai-Kuan ;
Wang, Wei-Shu ;
Lai, Jiun-I .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (05) :e283-e288
[3]  
Chen L, 2018, INT J MOL SCI, V19
[4]   Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer [J].
Chen, Lijian ;
Nan, Aruo ;
Zhang, Nan ;
Jia, Yangyang ;
Li, Xin ;
Ling, Yihui ;
Dai, Jiabin ;
Zhang, Shaozhu ;
Yang, Qiaoyuan ;
Yi, Yanni ;
Jiang, Yiguo .
MOLECULAR CANCER, 2019, 18 (1)
[5]   Maintenance of stable heterochromatin domains by dynamic HP1 binding [J].
Cheutin, T ;
McNairn, AJ ;
Jenuwein, T ;
Gilbert, DM ;
Singh, PB ;
Misteli, T .
SCIENCE, 2003, 299 (5607) :721-725
[6]   Natural RNA circles function as efficient microRNA sponges [J].
Hansen, Thomas B. ;
Jensen, Trine I. ;
Clausen, Bettina H. ;
Bramsen, Jesper B. ;
Finsen, Bente ;
Damgaard, Christian K. ;
Kjems, Jorgen .
NATURE, 2013, 495 (7441) :384-388
[7]   Small molecule inhibition of DDAH1 significantly attenuates triple negative breast cancer cell vasculogenic mimicry in vitro [J].
Hulin, Julie-Ann ;
Tommasi, Sara ;
Elliot, David ;
Mangoni, Arduino A. .
BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 :602-612
[8]   MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1 [J].
Hulin, Julie-Ann ;
Tommasi, Sara ;
Elliot, David ;
Hu, Dong Gui ;
Lewis, Benjamin C. ;
Mangoni, Arduino A. .
SCIENTIFIC REPORTS, 2017, 7
[9]   Upregulated circular RNA circ_0016760 indicates unfavorable prognosis in NSCLC and promotes cell progression through miR-1287/GAGE1 axis [J].
Li, Yongsheng ;
Hu, Jiahang ;
Li, Lijuan ;
Cai, Shengyan ;
Zhang, Hengchun ;
Zhu, Xianfeng ;
Guan, Guijie ;
Dong, Xiangmei .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) :2089-2094
[10]   circLPAR1 is a novel biomarker of prognosis for muscle-invasive bladder cancer with invasion and metastasis by miR-762 [J].
Lin, Guowen ;
Sheng, Haoyue ;
Xie, Huyang ;
Zheng, Qiupeng ;
Shen, Yijun ;
Shi, Guohai ;
Ye, Dingwei .
ONCOLOGY LETTERS, 2019, 17 (03) :3537-3547